| Assessment of Metabolic & Path Response w/ RCT & ImT Before Surgery in Locally Advanced Esoph and Gastro-esoph Jction CA (NCT03307941) | Jules Bordet Institute | 2017-07-20 |
| C-Met Inhibitor AMG 337, Oxaliplatin, Leucovorin Calcium, and Fluorouracil in Treating Patients With Advanced Stomach or Esophageal Cancer (NCT02344810) | Eastern Cooperative Oncology Group | 2015-03-06 |
| FOLFOX-6 Induction Chemotherapy Followed by Esophagectomy and Post-operative Chemoradiotherapy in Patients With Esophageal Adenocarcinoma (NCT02037048) | Case Comprehensive Cancer Center | 2014-02-10 |
| Pilot Trial of CRLX101 in Treatment of Patients With Advanced or Metastatic Stomach, Gastroesophageal, or Esophageal Cancer That Cannot be Removed by Surgery (NCT01612546) | City of Hope Medical Center | 2012-11-01 |
| Everolimus and Combination Chemotherapy in Treating Patients With Metastatic Stomach or Esophageal Cancer (NCT01231399) | City of Hope Medical Center | 2012-02-01 |
| Lapatinib With Carboplatin and Paclitaxel in Esophagus and Gastroesophageal Junction (GEJ) (NCT01395537) | Case Comprehensive Cancer Center | 2011-08-01 |
| Bevacizumab and Combination Chemotherapy Before Surgery in Treating Patients With Locally Advanced Esophageal or Stomach Cancer (NCT01212822) | Fox Chase Cancer Center | 2011-04-27 |
| Pralatrexate and Docetaxel in Treating Patients With Stage IV Esophageal or Gastroesophageal Cancer Who Have Failed Platinum-Based Therapy (NCT01129206) | Ohio State University Comprehensive Cancer Center | 2010-07-01 |
| Efficacy and Safety of OncoGelâ„¢ Added to Chemotherapy and Radiation Before Surgery in Subjects With Esophageal Cancer (NCT00573131) | Boston Scientific Corporation | 2008-01-01 |
| Oxaliplatin, Fluorouracil, Erlotinib Hydrochloride, and Radiation Therapy Before Surgery and Erlotinib Hydrochloride After Surgery in Treating Patients With Locally Advanced Cancer of the Esophagus or Gastroesophageal Junction (NCT01561014) | Wake Forest University Health Sciences | 2007-04-01 |
| Nodal Status in Adenocarcinoma of the Esophagus an Cardia (NCT01635595) | University of Bologna | 2006-01-01 |
| FR901228 in Treating Patients With Refractory Stomach Cancer or Gastroesophageal Junction Cancer (NCT00098527) | National Cancer Institute (NCI) | 2004-10-01 |
| 3-AP Plus Cisplatin in Treating Patients With Recurrent or Metastatic Adenocarcinoma of the Esophagus or Gastroesophageal Junction (NCT00077545) | National Cancer Institute (NCI) | 2004-01-01 |
| Arsenic Trioxide in Treating Patients With Advanced Cancer of the Esophagus or Gastroesophageal Junction (NCT00061958) | National Cancer Institute (NCI) | 2003-06-01 |
| Erlotinib Hydrochloride in Treating Patients With Advanced Esophageal Cancer or Stomach Cancer (NCT00045526) | National Cancer Institute (NCI) | 2002-06-01 |
| Antineoplaston Therapy in Treating Patients With Cancer of the Esophagus (NCT00003487) | Burzynski Research Institute | 1996-05-30 |